E-resources
Peer reviewed
Open access
-
Gerberich, B.G.; Hannon, B.G.; Hejri, A.; Winger, E.J.; Schrader Echeverri, E.; Nichols, L.M.; Gersch, H.G.; MacLeod, N.A.; Gupta, S.; Read, A.T.; Ritch, M.D.; Sridhar, S.; Toothman, M.G.; Gershon, G.S.; Schwaner, S.A.; Sánchez-Rodríguez, G.; Goyal, V.; Toporek, A.M.; Feola, A.J.; Grossniklaus, H.E.; Pardue, M.T.; Ethier, C.R.; Prausnitz, M.R.
Biomaterials, 04/2021, Volume: 271, Issue: CJournal Article
The central vision-threatening event in glaucoma is dysfunction and loss of retinal ganglion cells (RGCs), thought to be promoted by local tissue deformations. Here, we sought to reduce tissue deformation near the optic nerve head by selectively stiffening the peripapillary sclera, i.e. the scleral region immediately adjacent to the optic nerve head. Previous scleral stiffening studies to treat glaucoma or myopia have used either pan-scleral stiffening (not regionally selective) or regionally selective stiffening with limited access to the posterior globe. We present a method for selectively stiffening the peripapillary sclera using a transpupillary annular light beam to activate methylene blue administered by retrobulbar injection. Unlike prior approaches to photocrosslinking in the eye, this approach avoids the damaging effects of ultraviolet light by employing red light. This targeted photocrosslinking approach successfully stiffened the peripapillary sclera at 6 weeks post-treatment, as measured by whole globe inflation testing. Specifically, strain was reduced by 47% when comparing treated vs. untreated sclera within the same eye (n = 7, p=0.0064) and by 54% when comparing the peripapillary sclera of treated vs. untreated eyes (n = 7, p<0.0001). Post-treatment characterization of RGCs (optic nerve axon counts/density, and grading), retinal function (electroretinography), and retinal histology revealed that photocrosslinking was associated with some ocular toxicity. We conclude that a transpupillary photocrosslinking approach enables selective scleral stiffening targeted to the peripapillary region that may be useful in future treatments of glaucoma. Display omitted •Localized stiffening of the posterior eye may be a treatment strategy for glaucoma and myopia.•We sought to photocrosslink scleral collagen, using methylene blue as a photoinitiator, in vivo.•We stiffened an annular region around the optic nerve with a transpupillary red light beam.•Moderate treatment toxicity was identified using axon counts, histology, and electroretinography.
Author
![loading ... loading ...](themes/default/img/ajax-loading.gif)
Shelf entry
Permalink
- URL:
Impact factor
Access to the JCR database is permitted only to users from Slovenia. Your current IP address is not on the list of IP addresses with access permission, and authentication with the relevant AAI accout is required.
Year | Impact factor | Edition | Category | Classification | ||||
---|---|---|---|---|---|---|---|---|
JCR | SNIP | JCR | SNIP | JCR | SNIP | JCR | SNIP |
Select the library membership card:
If the library membership card is not in the list,
add a new one.
DRS, in which the journal is indexed
Database name | Field | Year |
---|
Links to authors' personal bibliographies | Links to information on researchers in the SICRIS system |
---|
Source: Personal bibliographies
and: SICRIS
The material is available in full text. If you wish to order the material anyway, click the Continue button.